Savant Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
32,536
+17,654
+119% +$197K ﹤0.01% 1453
2026
Q1
$161K Buy
14,882
+1,572
+12% +$13.5K ﹤0.01% 1443
2025
Q4
$81.3K Buy
13,310
+1,598
+14% +$9.54K ﹤0.01% 1344
2025
Q3
$60.7K Buy
11,712
+1,127
+11% +$6.48K ﹤0.01% 1297
2025
Q2
$62.8K Sell
10,585
-1,550
-13% -$9.33K ﹤0.01% 1216
2025
Q1
$99.8K Buy
+12,135
New +$102K ﹤0.01% 1038
2024
Q3
Sell
-17,251
Closed -$179K 1451
2024
Q2
$179K Buy
+17,251
New +$189K ﹤0.01% 1148

Other funds holding PTEN

Savant Capital's PTEN Position: Q2 2026 in Review

Savant Capital increased its Patterson-UTI (PTEN) stake by 119% in Q2 2026, buying an estimated $197K and bringing the position to 32,536 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

Savant Capital first reported a position in PTEN in Q2 2024 and has held it in 7 quarters since. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Savant Capital held 32,536 shares of Patterson-UTI worth $324K as of Q2 2026.
  • Savant Capital bought 17,654 Patterson-UTI shares in Q2 2026, an estimated $197K.
  • Patterson-UTI made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1453 holding.
  • Savant Capital first reported a position in Patterson-UTI in Q2 2024 and has held it in 7 quarters since.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.